AALR3 Stock Overview
Provides diagnostic medicine services in Brazil. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Alliança Saúde e Participações S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$6.30 |
| 52 Week High | R$17.32 |
| 52 Week Low | R$4.99 |
| Beta | 0.81 |
| 1 Month Change | -44.00% |
| 3 Month Change | -47.89% |
| 1 Year Change | -37.56% |
| 3 Year Change | -67.86% |
| 5 Year Change | -39.94% |
| Change since IPO | -67.19% |
Recent News & Updates
Return Trends At Alliança Saúde e Participações (BVMF:AALR3) Aren't Appealing
Apr 23
Alliança Saúde e Participações S.A.'s (BVMF:AALR3) 26% Price Boost Is Out Of Tune With Revenues
Mar 13Recent updates
Return Trends At Alliança Saúde e Participações (BVMF:AALR3) Aren't Appealing
Apr 23Alliança Saúde e Participações S.A.'s (BVMF:AALR3) 26% Price Boost Is Out Of Tune With Revenues
Mar 13Alliança Saúde e Participações (BVMF:AALR3) Seems To Use Debt Quite Sensibly
Feb 22There's Reason For Concern Over Alliança Saúde e Participações S.A.'s (BVMF:AALR3) Massive 37% Price Jump
Jan 26Alliança Saúde e Participações (BVMF:AALR3) Could Be Struggling To Allocate Capital
Dec 31Risks Still Elevated At These Prices As Alliança Saúde e Participações S.A. (BVMF:AALR3) Shares Dive 26%
Dec 05Alliança Saúde e Participações S.A. (BVMF:AALR3) Stock Rockets 36% As Investors Are Less Pessimistic Than Expected
Aug 25Optimistic Investors Push Alliança Saúde e Participações S.A. (BVMF:AALR3) Shares Up 60% But Growth Is Lacking
Jul 11What Alliança Saúde e Participações S.A.'s (BVMF:AALR3) 26% Share Price Gain Is Not Telling You
Apr 17Centro de Imagem Diagnósticos (BVMF:AALR3) Will Be Hoping To Turn Its Returns On Capital Around
Aug 17Why Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Could Be Worth Watching
Jul 08Is Centro de Imagem Diagnósticos (BVMF:AALR3) Using Too Much Debt?
May 28What Is Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Share Price Doing?
Apr 05Reflecting on Centro de Imagem Diagnósticos' (BVMF:AALR3) Share Price Returns Over The Last Three Years
Mar 10Should You Buy Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) For Its Dividend?
Feb 17What Percentage Of Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Shares Do Insiders Own?
Jan 27
Would Centro de Imagem Diagnósticos (BVMF:AALR3) Be Better Off With Less Debt?
Jan 06What Does Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Share Price Indicate?
Dec 11Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Is Yielding 0.8% - But Is It A Buy?
Aug 07Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Jul 20Is Centro de Imagem Diagnósticos (BVMF:AALR3) Likely To Turn Things Around?
Jul 03Shareholder Returns
| AALR3 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | 12.7% | 1.2% | 1.8% |
| 1Y | -37.6% | -6.0% | -0.6% |
Return vs Industry: AALR3 underperformed the BR Healthcare industry which returned -5.6% over the past year.
Return vs Market: AALR3 underperformed the BR Market which returned -1.8% over the past year.
Price Volatility
| AALR3 volatility | |
|---|---|
| AALR3 Average Weekly Movement | 12.2% |
| Healthcare Industry Average Movement | 7.9% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in BR Market | 9.6% |
| 10% least volatile stocks in BR Market | 2.8% |
Stable Share Price: AALR3's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: AALR3's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of BR stocks.
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | n/a | Isabella Correa | www.allianca.com |
Alliança Saúde e Participações S.A. provides diagnostic medicine services in Brazil. It offers imaging diagnosis and graphic methods; nuclear medicine cytology; pathological anatomy; human vaccination and immunization; medical activity; and clinical analysis, as well as other auxiliary diagnostic support services. The company also engages in the import of medical and hospital equipment, diagnostic sets, and related items; provision of consultancy, advice, courses, and lectures in the health area; managing chronic diseases; research and development in the area of diagnostic medicine; preparation, editing, publication, and distribution of newspapers, books, magazines, periodicals, and other written communication vehicles intended for scientific dissemination; and granting and administration of business franchises.
Alliança Saúde e Participações S.A. Fundamentals Summary
| AALR3 fundamental statistics | |
|---|---|
| Market cap | R$744.67m |
| Earnings (TTM) | -R$129.12m |
| Revenue (TTM) | R$1.22b |
0.6x
P/S Ratio-5.8x
P/E RatioIs AALR3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AALR3 income statement (TTM) | |
|---|---|
| Revenue | R$1.22b |
| Cost of Revenue | R$861.34m |
| Gross Profit | R$355.66m |
| Other Expenses | R$484.78m |
| Earnings | -R$129.12m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
May 15, 2025
| Earnings per share (EPS) | -1.09 |
| Gross Margin | 29.22% |
| Net Profit Margin | -10.61% |
| Debt/Equity Ratio | 63.5% |
How did AALR3 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/24 02:34 |
| End of Day Share Price | 2025/04/23 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Alliança Saúde e Participações S.A. is covered by 8 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pedro Mariani | BofA Global Research |
| Carlos Palhares Sequeira | BTG Pactual |
| Giovana Scottini | Eleven Financial Research |